Laurus Labs to acquire 52% stake in Hyderabad-based SI&C Resins for ₹32.5 crore | Hyderabad News

Hyderabad: Laurus Labs Ltd will be acquiring a 52% stake in Hyderabad-based SI & C Resins Private Ltd for ₹32.5 crore in an all cash deal that is aimed at strengthening its peptide manufacturing capabilities, the company said in a regulatory filing on Thursday.The transaction will be executed through a primary subscription to 10,833 equity shares of SI&C, representing 52% of its post-issue paid-up equity capital and post the closure of the deal SI&C will become a subsidiary of Laurus Labs. The board of Laurus Labs approved the acquisition at a meeting held on Thursday.The acquisition values SI&C at a pre-money valuation of ₹30 crore. Laurus said it may also invest up to ₹30 crore more in securities to be issued by SI&C as and when it requires funds.SI&C manufactures polymer and silica-based products used in the chemical, pharmaceutical and biotechnology industries. Its products are used in peptide and peptidomimetic synthesis, absorption and separation of heavy metals, oxidation and reduction of functional groups, and counter-ion exchange of small molecules and active pharmaceutical ingredients.Laurus said the investment forms part of its broader peptide strategy and will help make its peptide manufacturing offerings “fully integrated.” The company said indigenous resin and chromatography gel development, along with large-scale manufacturing, would help it capture integrated peptide manufacturing opportunities.SI&C, which was incorporated on July 15, 2026, is expected to take over the business of a partnership firm SI & C Resins, which was registered in 2022 and reported a turnover of ₹3.55 crore in FY25 and ₹4.05 crore in FY26, according to the filing.Laurus Labs said the proposed transaction is expected to be completed during the current financial year, subject to customary closing conditions and agreements, including transfer of the partnership firm’s business.